Toxicological Studies with Nanoscale Materials

Nanotechnology Environmental Health and Safety

Volumn , Issue , 2010, Pages 3-47

  Santamaria, Annette B ^a   Sayes, Christie M ^b  

^a Health Sciences Practice of ENVIRONInternational Corporation   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884447905     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-8155-1586-9.10001-5     Document Type: Chapter

References (90)

1. Adamson A.W., Gast A.P. Physical Chemistry of Surfaces 1997, Wiley, New York.
2. Agarwal A., Lariya N., Saraogi G., et al. Nanoparticles as novel carrier for brain delivery: a review. Current Pharmaceutical Design 2009, 15(8):917-925.
3. Aschner M., Guilarte T.R., Schneider J.S., Zheng W. Manganese: recent advances in understanding its transport and neurotoxicity. Toxicology and Applied Pharmacology 2007, 221(2):131-147.
4. Bai S., Thomas C., Rawat A., Ahsan F. Recent progress in dendrimer-based nanocarriers. Critical Reviews in Therapeutic Drug Carrier Systems 2006, 23(6):437-495.
5. Baker G.L., Gupta A., Clark M.L., et al. Inhalation Toxicity and Lung Toxicokinetics of C60 Fullerene Nanoparticles and Microparticles. Toxicology Science 2008, 101(1):122-131.
6. Bockmann J., Lahl H., Eckert T., Unterhalt B. Titanium blood levels of dialysis patients compared to healthy volunteers. Pharmazie 2005, 55(6):468.
7. Borm P., Robbins D., Haubold S., et al. The potential risks of nanomaterials: a review carried out for ECETOC. Particle and Fibre Toxicology 2006, 3:1-35.
8. Bucher, J., S. Masten, B. Moudgil, et al., 2004. Developing Experimental Approaches for the Evaluation of Toxicological Interactions of Nanoscale Materials. Final Workshop Report 3-4 November 2004, University of Florida, Gainesville, FL. Available at:. http://www.nanotoxicology.ufl.edu/workshop/images/NanoToxWorkshop.pdf.
9. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicological Sciences 2005, 88:412-419.
10. Brook R.D. Cardiovascular effects of air pollution. Clinical Science 2008, 115(6):175-187.
11. Brunauer S., Emmett P.H., Teller E. Adsorption of gases in multimolecular layers. Journal of the American Chemical Society 1938, 60:309-319.
12. Christenson E.M., Anseth K.S., van den Beucken J.J., et al. Nanobiomaterial applications in orthopedics. Journal of Orthopedic Research 2007, 25(1):11-22.
13. des Rieux A., Fievez V., Garinot M., et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. Journal of Control Release 2006, 1:1-27.
14. Doull J., Borzelleca J.F., Becker R., et al. Framework for use of toxicity screening tools in context-based decision-making. Food and Chemical Toxicology 2007, 45(5):759-796.
15. Environmental Defense and DuPont Nano Risk Framework 2007, EDF, New York.
16. Galindo-Rodriguez S.A., Allemann E., Fessi H., Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Critical Reviews in Therapeutic Drug Carrier Systems 2005, 22(5):419-464.
17. Gamer A.O., Leibold E., van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin,. Toxicology in Vitro 2006, 20(3):301-307.
18. Gopee N.V., Roberts D.W., Webb P., et al. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicological Sciences 2007, 98(1):249-257.
19. 3 nanoparticles on oxidative stress in cultured lung epithelial cells. Particle and Fibre Toxicology 2009, 9(6):4.
20. Hadgraft J., Lane M.E. Skin permeation: the years of enlightenment. International Journal of Pharmaceutics 2005, 305(1-2):2-12.
21. Hagens W.I., Oomen A.G., de Jong W.H., et al. What do we (need to) know about the kinetic properties of nanoparticles in the body?. Regulatory Toxicology and Pharmacology 2007, 49(3):217-229.
22. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors,. Environmental Health Perspectives 2006, 114(2):165-172.
23. Haws L., Harris M., Su S., et al. Development of a refined database of relative potency estimates to facilitate better characterization of variability and uncertainty in the current mammalian TEFs for PCDDs, PDCFs, and dioxin-like PCBs. Organohalogen Compounds 2004, 66:3426-3432.
24. Helland A., Wick P., Koehler A., et al. Reviewing the environmental and human health knowledge base of carbon nanotubes. Environmental Health Perspectives 2007, 115(8):1125-1131.
25. Hussain S.M., Hess K.L., Gearhart J.M., et al. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicology in Vitro 2005, 19:975-983.
26. Isakovic A., Markovic Z., Todorovic-Markovic B., et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicological Sciences 2006, 91(1):173-183.
27. Ji J.H., Jung J.H., Kim S.S., et al. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhalation Toxicology 2007, 19(10):857-871.
28. Juillerat-Jeanneret L. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?. Drug Discovery Today 2008, 13(23-24):1099-1106.
29. Kanikkannan N., Kandimalla K., Lamba S.S., Singh M. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. Current Medicinal Chemistry 2000, 7(6):593-608.
30. Kogan A., Garti N. Microemulsions as transdermal drug delivery vehicles. Advances in Colloid and Interface Sciences 2006, 123-126. 369-385.
31. Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. Journal of Nanoscience and Nanotechnology 2004, 4(5):484-488.
32. Lam C.W., James J.T., McCluskey R., Hunter R.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicological Sciences 2004, 77:126-134.
33. Levin J., Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview,. Journal of Control Release 2005, 103(2):291-299.
34. Lockman P.R., Koziara J.M., Mumper R.J., Allen D.D. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. Journal of Drug Targeting 2004, 12:635-641.
35. Malik D.K., Baboota S., Ahuja A., Hasan S., Ali J. Recent advances in protein and peptide drug delivery systems. Current Drug Delivery 2007, 2:141-151.
36. Mavon A., Miquel C., Lejeune O., Payre P., Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacology and Physiology 2007, 20(1):10-20. m.
37. Maynard A.D., Aitken R., Tilman B., et al. Safe Handling of Nanotechnology. Nature 2006, 444(16):267-269.
38. Monteiro-Riviere N.A., Nemanich R.J., Inman A.O., et al. Multi-walled carbon nanotube interactions with human epidermal keratinocytes. Toxicology Letters 2005, 155(3):377-384.
39. Monteiro-Riviere N.A., Inman A.O., Zhang L.W. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicology and Applied Pharmacology 2008.
40. Muller J., Delos M., Panin N., et al. Absence of carcinogenic response to multi-wall carbon nanotubes in a 2-year bioassay in the peritoneal cavity of the rat. Toxicological Sciences 2009, 8. May.
41. Murray A.R., Kisin E., Leonard S.S., et al. Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes. Toxicology 2009, 257(3):161-171.
42. Nanoderm Quality of Skin as a Barrier to ultra-fine Particles: Final Report 2007, Nanoderm, Brussels.
43. National Research Council Risk Assessment in the Federal Government: Managing the Process 1983, National Academy Press, Washington, DC.
44. National Research Council Science and judgment in risk assessment. Committee on Risk Assessment of Hazardous Air Pollutants 1994, National Academy Press, Washington, DC.
45. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
46. Nohynek G.J., Lademann J., Ribaud C., Roberts M.S. Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety. Critical Reviews in Toxicology 2007, 37(3):251-277.
47. Nohynek G.J., Dufour E.K., Roberts M.S. Nanotechnology, cosmetics and the skin: is there a health risk?. Skin Pharmacology and Physiology 2008, 21(3):136-149.
48. Nygaard U.C., Hansen J.S., Samuelsen M., et al. Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. Toxicological Sciences 2009, 109(1):113-123.
49. Oberdörster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environmental Health Perspective 2004, 112(10):1058-1062.
50. Oberdörster, G., Oberdörster, E., and Oberdörster, J., 2005a. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles, Environmental Health Perspective 113, 823-839.
51. Oberdörster, G., Maynard, A.D., Donaldson, K., et al. 2005b. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy, Particle and Fibre Toxicology 2(8).
52. Park B., Donaldson K., Duffin R., et al. Hazard and risk assessment of a nanoparticulate cerium oxide-based diesel fuel additive - a case study. Inhalation Toxicology 2008, 20(6):547-566.
53. Park S., Lee Y.K., Jung M., et al. Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhalation Toxicology 2007, 19(1):59-65.
54. Petry T., Schmid P., Schlatter C. The use of toxic equivalency factors in assessing occupational and environmental health risk associated with exposure to airborne mixtures of polycyclic aromatic hydrocarbons (PAHs). Chemosphere 1996, 32(4):639-648.
55. Poland C.A., Duffin R., Kinloch I., et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature Nanotechnology 2008, 3(7):423-428.
56. Powers K.W., Brown S.C., Krishna V.B., et al. Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicological Sciences 2006, 90:296-303.
57. Powers K.W., Palazuelos M., Moudgil B.M., Roberts S.M. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 2007, 1(1):42-51.
58. Purchase I.F.H. Risk assessment. Principles and consequences. Pure and Applied Chemistry 2000, 72(6):1051-1056.
59. Ratner B.D. Biomaterials Science: An Introduction to Materials in Medicine 1996, Academic Press, San Diego.
60. Rouse J.G., Yang J., Ryman-Rasmussen J.P., et al. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Letters 2007, 7(1):155-160.
61. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicological Sciences 2006, 91(1):159-165.
62. Sakamoto Y., Nakae D., Fukumori N., et al. Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. Journal of Toxicological Sciences 2009, 34(1):65-76.
63. Sayes C.M., Fortner J., Wehn G., et al. The differential cytotoxicity of water soluble fullerenes. Nano Letters 2004, 4(10):1881-1887.
64. Sayes C.M., Liang F., Hudson J.L., et al. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicological Letters 2006, 161(2):135-142.
65. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicological Sciences 2007, 97(1):163-180.
66. Scientific Committee on Emerging and Newly Identified Health Risks Modified Opinion (after public consultation) on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. Health and Consumer Protection Directorate-General 2006, European Commission, Brussels.
67. Scientific Committee on Emerging and Newly Identified Health Risks Opinion on the appropriateness of the risk assessment methodology in accordance with the technical guidance documents for new and existing substances for assessing the risks of nanomaterials. Health and Consumer Protection Directorate-General 2007, European Commission, Brussels.
68. Shvedova A.A., Castranova V., Kisin E.R., et al. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. Journal of Toxicology and Environmental Health 2003, A66:1909-1926.
69. Shvedova A.A., Kisin E., Murray A.R., et al. Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. American Journal of Physiology - Lung Cellular and Molecular Physiology 2008, 295(4):L552-L565.
70. Shvedova A.A., Kisin E.R., Porter D., et al. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus?. Pharmacology and Therapeutics 2009, 121(2):192-204.
71. Silva G.A. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier. Surgical Neurology 2007, 2:113-116.
72. Sint T., Donohue J.F., Ghio A.J. Ambient air pollution particles and the acute exacerbation of chronic obstructive pulmonary disease. Inhalation Toxicology 2008, 20(1):25-29.
73. Stern S.T., McNeil S.E. Nanotechnology Safety Concerns Revisited. Toxicology Science 2008, 101(1):4-21.
74. Stone V., Johnston H., Clift M.J. Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans Nanobioscience 2007, 6(4):331-340.
75. Takagi A., Hirose A., Nishimura T., et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotubes. Journal of Toxicological Science 2008, 33(1):105-116.
76. Teeguarden J.G., Hinderliter P.M., Orr G., et al. Particokinetics in vitro: Dosimetry Considerations for in vitro Nanoparticle Toxicity Assessments. Toxicological Sciences 2007, 95(2):300-312.
77. Tsuji J.S., Maynard A.D., Howard P.C., et al. Research Strategies for Safety Evaluation of Nanomaterials, Part IV: Risk Assessment of Nanoparticles. Toxicology Sciences 2006, 89(1):42-50.
78. Tran C.L., Buchanan D., Cullen R.T., et al. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhalation Toxicology 2000, 12:1113-1126.
79. Tran C.L., Donaldson K., Stone V., et al. A scoping study to identify hazard data needs for addressing the risks presented by nanoparticles and nanotubes 2005, Institute of Occupational Medicine, Edinburgh.
80. Van den Berg M., Birnbaum L.S., Denison M., et al. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicology Sciences 2006, 93(2):223-241.
81. Wang, J., Chen, C., Liu, Y., et al. 2008a. Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases, Toxicology Letters 183(1-3), 72-80.
82. Wang, J., Liu, Y., Jiao, F., et al., 2008b. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles, Toxicology 254(1-2), 82-90.
83. Wang M.D., Shin D.M., Simons J.W., Nie S. Nanotechnology for targeted cancer therapy. Expert Review of Anticancer Therapy 2007, 7(6):833-837.
84. Warheit, D.B, Hoke, R.A., Finlay, C., et al., 2007a. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management, Toxicology Letters 171, 99-110.
85. Warheit, D.B., Borm, P.J., Hennes, C., and Lademann, J., 2007b. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop, Inhalation Toxicology 19(8), 631-643.
86. Warheit, D.B, Webb, T.R., Reed, K.L., et al., 2007c. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties, Toxicology 230(1), 90-104.
87. Warheit D.B., Laurence B.R., Reed K.L., et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicology Science 2004, 77(1):117-125.
88. Williams D. Carbon nanotubes in medical technology. Medical Device Technology 2007, 8(2):8-10.
89. Yang X. Nano- and microparticle-based imaging of cardiovascular interventions: overview. Radiology 2007, 243(2):340-347.
90. Zhang L.W., Monteiro-Riviere N.A. Assessment of quantum dot penetration into intact, tape-stripped, abraded and flexed rat skin. Skin Pharmacology and Physiology 2008, 21(3):166-180.